Pharma Dubs EU HTA Proposal ‘Unworkable,’ But Patient Groups Support The Plan

Pharmaceutical companies, NGOs, and patient organizations were among the 129 respondents to the European Commission’s consultation on its draft implementing act for joint clinical assessments – but opinions on the proposal were divided.

Thumbs down, thumbs up thumbs disagree — • Source: Shutterstock

The European Commission’s proposed implementing act for EU-level joint clinical assessments (JCAs), a key element of the upcoming Health Technology Assessment Regulation ((EU) 2021/2282), has been described as “unworkable” by the pharma industry.

The European Association for Bioindustries (Europabio), for example, said it was concerned that the commission’s proposal for implementing JCAs, which...